Literature DB >> 5143816

Impairement of drug metabolism in tumor-bearing animals.

R Rosso, M G Donelli, G Franchi, S Garattini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5143816     DOI: 10.1016/0014-2964(71)90064-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  13 in total

1.  The distribution and kinetics of sulphacetamide in leukaemic mice.

Authors:  C Marchand; D Nadeau
Journal:  Br J Pharmacol       Date:  1976-04       Impact factor: 8.739

2.  Microsomal enzymes in patients with acute leukemia as determined by plasma half-life of antipyrine.

Authors:  T Higuchi; T Nakamura; H Uchino
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  Influence of tumor on adriamycin concentration in blood cells.

Authors:  M Broggini; T Colombo; S Garattini; M G Donelli
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 4.  Genetic predisposition to lung cancer.

Authors:  M R Law
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

5.  Antipyrine metabolism in cancer patients.

Authors:  T Higuchi; T Nakamura; H Uchino
Journal:  Experientia       Date:  1980-02-15

6.  Protection of bone-marrow granulocyte-macrophage colony-forming units in mice bearing in vivo alkylating-agent-resistant EMT-6 tumors.

Authors:  B A Teicher; D Chatterjee; J T Liu; S A Holden; G Ara
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  Effects of advanced leukemia on hepatic drug-metabolizing activity in the mouse.

Authors:  G Powis; R N Harris; P J Basseches; K S Santone
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

8.  Pharmacokinetics of fotemustine and BCNU in plasma, liver and tumor tissue of rats bearing two lines of Walker 256 carcinoma.

Authors:  A Guaitani; M Corada; C Lucas; A Lemoine; S Garattini; I Bartosek
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

9.  Variability of tumor response to chemotherapy. I. Contribution of host heterogeneity.

Authors:  L Simpson-Herren; P E Noker; S D Wagoner
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

10.  P-aminosalicylate metabolism in cancer patients sensitive and resistant to chemotherapy.

Authors:  J G Lavigne; A Barry; C d'Auteuil; J M Delage
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.